Monday, 14 September 2026European Markets

CAIRN HOMES PLC And ABEO Have A High Dividend Yield And Return On Equity In The Consumer Cyclical Sector.

Loading stream...

(vianews) - cairn homes plc (c5h.ir) is among this list of stock assets with the highest dividend rate and return on equity on the consumer cyclical sector.

financial asset price forward dividend yield return on equity
cairn homes plc (c5h.ir) €1.01 5.9% 10.59%
abeo (abeo.pa) €16.40 2.07% 8.59%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. cairn homes plc (c5h.ir)

5.9% forward dividend yield and 10.59% return on equity

cairn homes plc operates as a homebuilder in ireland. it is involved in the development and sale of residential properties, as well as rental of properties. the company was incorporated in 2014 and is based in dublin, ireland.

earnings per share

as for profitability, cairn homes plc has a trailing twelve months eps of €0.11.

pe ratio

cairn homes plc has a trailing twelve months price to earnings ratio of 9.22. meaning, the purchaser of the share is investing €9.22 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.59%.

volume

today's last reported volume for cairn homes plc is 337351 which is 60.53% below its average volume of 854855.

volatility

cairn homes plc's last week, last month's, and last quarter's current intraday variation average was a positive 0.81%, a negative 0.08%, and a positive 1.25%.

cairn homes plc's highest amplitude of average volatility was 1.21% (last week), 1.34% (last month), and 1.25% (last quarter).

yearly top and bottom value

cairn homes plc's stock is valued at €1.01 at 12:30 est, way below its 52-week high of €1.29 and way higher than its 52-week low of €0.80.

dividend yield

as claimed by morningstar, inc., the next dividend payment is on apr 20, 2023, the estimated forward annual dividend rate is 0.06 and the estimated forward annual dividend yield is 5.9%.

more news about cairn homes plc.

2. abeo (abeo.pa)

2.07% forward dividend yield and 8.59% return on equity

abéo sa designs, manufactures, and distributes sports and leisure equipment in france and internationally. it offers gymnastics apparatus and landing mats, team sports equipment, physical education, climbing walls, and changing room fittings. it offers its products under the gymnova, janssen-fritsen, spieth gymnastics, schelde sports, spieth america, sportsafe, erhard sport, adec sport, o'jump, cannice, bosan, pcv, vogoscope, bigairbag, entre-prises, clip'n climb, top30, fun spot, climbat, france equipement, meta, prospec, navic, sanitec, suffixe, and sanelite brands. the company was founded in 1955 and is headquartered in rioz, france.

earnings per share

as for profitability, abeo has a trailing twelve months eps of €1.27.

pe ratio

abeo has a trailing twelve months price to earnings ratio of 12.91. meaning, the purchaser of the share is investing €12.91 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.59%.

more news about abeo.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Keeps Flowing as Enterprise Adoption and Government Contracts Validate the Bet
A late-August surge of nine-figure funding rounds (Socure, Stability AI, Generalist AI, Gatik, Regent Craft, Emerald AI, Owner) shows venture capital still pouring into AI infrastructure, identity/fintech, and autonomy, even as public-market sentiment stays jumpy — Palantir's stock fell 6% the same week it landed the Army's TITAN contract. UiPath's raised guidance and strong Q2 results, alongside efficiency breakthroughs like Multiverse Computing's model compression, point to real enterprise monetization catching up to the funding hype.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts record the same attribute (net_income) for JPMorgan Chase & Co. in the identical fiscal period (Q1 2026) and observation date (2026-03-31), but report values that differ by approximately 1 billion times: $16,494,000,000 vs $16.49. These cannot both be true simultaneously. The discrepancy suggests either a unit mismatch (e.g., one is total net income, the other earnings per share mislabeled as net_income), a decimal point error, or data entry corruption. For the same entity, attribute, and time period, only one value can be correct.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,285 source documents archived
Query this data → isubstrate.com